high quality bpc 157 BPC-157 – Research Peptide BPC-157 5mg & 10mg Research

some protocols may use twice-weekly injections or injections every other week, depending on your individual needs and how you respond to therapy

Your sample is routed directly to our CQC-regulated UK laboratory for expert analysis, guaranteeing hospital-grade accuracy and strict data privacy

It stimulates lipolysis and inhibits lipogenesis, targeting fat metabolism directly while sparing lean muscle

Healthletic offers a 30-day return policy

AOD-9604 FDA Approval History At a glance FDA approval status / Never approved for any indication in the United States NDA filing history / No New Drug Application has ever been submitted to FDA Chemical identity / Synthetic peptide corresponding to amino acids 176-191 of human growth hormone, with a tyrosine residue added at the C-terminus Developer / Metabolic Pharmaceuticals Ltd (Melbourne, Australia), now defunct Clinical trial outcome / Phase IIb trial (2007) failed to meet primary efficacy endpoint for obesity FDA compounding status / Placed on Category 2 list